HUME RICHARD T 4
4 · TD SYNNEX CORP · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
TD SYNNEX (SNX) Director Richard Hume Exercises Options, Sells 492 Shares
What Happened
- Richard T. Hume, a director of TD SYNNEX Corp. (SNX), exercised 492 stock options (fully vested) on 2026-01-30 at an exercise price of $107.32 per share (total exercise cost $52,801) and immediately sold the 492 shares in the open market for a weighted average price of $160.41 per share (gross proceeds $78,922). The net proceeds from the sale were roughly $26,121 before taxes and fees. The transactions were executed under a Rule 10b5-1 trading plan.
Key Details
- Transaction date: 2026-01-30; Form 4 filed: 2026-02-02.
- Exercise: 492 shares @ $107.32 (total $52,801) — transaction code M (option exercise).
- Sale: 492 shares @ weighted avg $160.41 (total $78,922) — transaction code S.
- Weighted average sale price ranged from $160.035 to $160.805 (reporting person can provide breakdown on request).
- Option status: fully vested (footnote F3).
- Plan: trades were effected pursuant to a 10b5-1 plan adopted July 14, 2025 (footnote F1).
- Shares owned after the transactions: not specified in the provided filing excerpt.
- No late-filing flag noted in the provided details.
Context
- This is a classic exercise-and-sell (cashless exercise) sequence: the director exercised vested options and sold the resulting shares, a common way to cover exercise costs and taxes. Transactions were pre-planned under a 10b5-1 plan, which can indicate the timing was set in advance rather than based on immediate insider insight.
Insider Transaction Report
Form 4
HUME RICHARD T
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-30$107.32/sh+492$52,801→ 48,007 total - Sale
Common Stock
[F1][F2]2026-01-30$160.41/sh−492$78,922→ 47,515 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F1][F3]2026-01-30−492→ 18,365 totalExercise: $107.32Exp: 2031-10-05→ Common Stock (492 underlying)
Footnotes (3)
- [F1]The stock option exercises and sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.
- [F2]Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.035 to $160.805. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
- [F3]This stock option is fully vested.
Signature
/s/ Cheryl Grant, attorney-in-fact|2026-02-02